Ads
related to: tof echo findings in ultrasound procedure for prostate cancer- About Us
Understand how a PSMA PET scan may
help with your treatment plan.
- Talk To Your Doctor
Review questions to start a
conversation with your doctor.
- Reimbursement Support
The patient support program
can assist insurance assessment.
- Find An Imaging Site
Locate the nearest imaging site
or contact customer service.
- About Us
Search results
Results from the WOW.Com Content Network
Transrectal ultrasonography, or TRUS in short, is a method of creating an image of organs in the pelvis, most commonly used to perform an ultrasound-guided needle biopsy evaluation of the prostate gland in men with elevated prostate-specific antigen or prostatic nodules on digital rectal exam.
Transrectal biopsy is a biopsy procedure in which a sample of tissue is removed from the prostate using a thin needle that is inserted through the rectum and into the prostate. [1] Transrectal ultrasound (TRUS) is usually used to guide the needle. [2] [3] The sample is examined under a microscope to see if it contains cancer.
TOFD has a dead zone where it is not sensitive to defects, hence TOFD ought always to be supplemented by a conventional pulse-echo examination or phased array. The pulse echo probes are commonly mounted on the same buggy as the TOFD probes. Requires ultrasound technicians with advanced training.
Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Once patients are placed in prognostic categories, this information can contribute to the selection of an optimal approach ...
Endogenous stones: These are small stones formed within the acini of the prostate. They have a higher correlation with age. [3] Extrinsic stones: These stones are usually larger and formed due to the reflux of urine into the prostate. [3] The exact mechanism of the development of prostatic calculi is still unclear. [3]
Prostate cancer antigen 3 is a urine test that detects the overexpression of the PCA3 gene, an indicator of prostate cancer. [32] [46] [47] [44] ConfirmMDx is performed on tissue taken during a prostate biopsy. The test identifies men with clinically significant prostate cancer who would benefit from further testing and treatment.
Ads
related to: tof echo findings in ultrasound procedure for prostate cancer